Debt to Equity Ratio Chart

View Debt to Equity Ratio for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 0.0099
March 31, 2026 0.011
December 31, 2025 0.0102
September 30, 2025 0.0102
June 30, 2025 0.0113
March 31, 2025 0.0101
December 31, 2024 0.0112
September 30, 2024 0.0107
June 30, 2024 0.0119
March 31, 2024 0.0131
December 31, 2023 0.0141
September 30, 2023 0.0114
June 30, 2023 0.0126
March 31, 2023 0.0095
December 31, 2022 0.1668
September 30, 2022 0.1387
June 30, 2022 0.1411
March 31, 2022 0.1366
December 31, 2021 0.1318
September 30, 2021 0.1616
June 30, 2021 0.136
March 31, 2021 0.082
December 31, 2020 0.096
September 30, 2020 0.0906
June 30, 2020 0.0918
Date Value
March 31, 2020 0.0949
December 31, 2019 0.982
September 30, 2019 0.2438
June 30, 2019 0.234
March 31, 2019 0.2245
December 31, 2018 0.2965
September 30, 2018 0.285
June 30, 2018 0.3063
March 31, 2018 0.2196
December 31, 2017 0.1604
September 30, 2017 0.0115
June 30, 2017 0.0145
March 31, 2017 0.0154
December 31, 2016 0.0158
September 30, 2016 0.017
June 30, 2016 0.0179
March 31, 2016 0.0271
December 31, 2015 0.0248
September 30, 2015 0.0259
June 30, 2015 0.0254
March 31, 2015 0.0273
December 31, 2014 0.0281
September 30, 2014 0.0879
June 30, 2014 0.0826
March 31, 2014 0.0799

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Evaxion AS 0.7455
Genmab A/S 0.8852
Ascendis Pharma A/S 0.3133
Zealand Pharma A/S 0.0228
Agenus, Inc. -1.458